Bone Marrow TransplantationMultiple MyelomaHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousBone MarrowGraft vs Host DiseaseBone Marrow CellsTransplantation ConditioningStem CellsPeripheral Blood Stem Cell TransplantationLiver TransplantationWhole-Body IrradiationTransplantation ChimeraTissue DonorsHematopoietic Stem CellsGraft SurvivalHematologic NeoplasmsLeukemiaBusulfanTreatment OutcomeHistocompatibility TestingKidney TransplantationAnemia, AplasticBone and BonesRecurrenceMelphalanHistocompatibilityCombined Modality TherapyCyclophosphamideRemission InductionBone Marrow PurgingTransplantation, IsogeneicImmunosuppressive AgentsCord Blood Stem Cell TransplantationTime FactorsRetrospective StudiesMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteCell TransplantationHematopoiesisTransplantation ImmunologyHeart TransplantationGraft RejectionSurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsSurvival RateLymphoma, Non-HodgkinMice, Inbred C57BLLung TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalBone Marrow DiseasesCell DifferentiationGraft vs Leukemia EffectBoronic AcidsImmunosuppressionHematopoietic Stem Cell MobilizationLymphocyte DepletionHLA AntigensHematologic DiseasesMyelodysplastic SyndromesPyrazinesGraft vs Tumor EffectLymphocyte TransfusionAcute DiseaseFollow-Up StudiesOrgan TransplantationAntigens, CD34Radiation ChimeraLeukemia, MyeloidThalidomideT-LymphocytesBone Marrow ExaminationSevere Combined ImmunodeficiencySalvage TherapyEmbryonic Stem CellsGranulocyte Colony-Stimulating FactorCarmustinePrognosisFlow CytometryCyclosporineMyeloma ProteinsCytarabineCytomegalovirus InfectionsLeukocyte TransfusionChimerismPlasma CellsAdult Stem CellsCells, CulturedColony-Forming Units AssayEtoposideGraft vs Host ReactionHodgkin DiseaseLymphomaAntilymphocyte Serum